Heart-Lung Machine: ASELSAN’s Innovative Health Technology
**ASELSAN has made a significant leap in healthcare technology with its groundbreaking Heart-Lung Machine, which has successfully completed blood testing.** This revolutionary device, developed entirely in Turkey, aims to enhance life support capabilities during open-heart surgeries. ASELSAN’s commitment to health continues to grow, focusing on both life support systems and advanced medical imaging.
The unveiling event at the Expomed Fair highlighted ASELSAN’s efforts, with the participation of Minister of Health, Prof. Dr. Kemal Memişoğlu. The Heart-Lung Machine is engineered to take over the functions of the heart and lungs, making it a critical tool for surgeons.
ASELSAN’s work on the Heart-Lung Machine began in 2020 and reflects the company’s dedication to innovation. The device has already garnered attention, winning industrial design awards from renowned institutions such as If Design, A’Design, and IDA Design. Its design process incorporated feedback from medical professionals, ensuring practicality and usability in real-world hospital environments.
Collaborating with the Turkish Health Institutes Presidency (TÜSEB), ASELSAN is advancing the clinical study of the device, which is expected to be available for hospital use by next year. This initiative not only underscores its local production capabilities but also emphasizes the strategic goal of bolstering Turkey’s self-sufficiency in healthcare technology.
With a high local content ratio, the Heart-Lung Machine is poised to aid in reducing Turkey’s trade deficit and is targeted for export to markets worldwide. ASELSAN’s rich experience in the defense industry is being leveraged to decrease foreign dependency, positioning the company as a formidable player in the global health sector.
In addition to the Heart-Lung Machine, ASELSAN is broadening its footprint by developing other innovative healthcare solutions. This includes mobile digital X-ray devices (ADR-M100), various models of automatic external defibrillators, and a variety of biomedical devices that cater to diverse medical needs.
Looking ahead, ASELSAN aims to expand its product portfolio further to include cutting-edge technologies such as magnetic resonance imaging (MRI), computed tomography (CT), ultrasonography, and bedside monitoring systems. Such advancements reflect ASELSAN’s commitment to enhancing healthcare services not only in Turkey but across the globe.
Moreover, ASELSAN’s national Mobile X-Ray Device is ready for mass production, marking another milestone in its healthcare initiatives. This device is set to provide essential diagnostic capabilities, particularly in emergencies, aligning with ASELSAN’s mission to deliver innovative, life-saving technologies.
